50
Participants
Start Date
June 30, 2026
Primary Completion Date
April 30, 2028
Study Completion Date
April 30, 2029
Bone Marrow Aspirate (BMA)
Bone marrow aspirate (BMA) is being investigated as an augmentation to arthroscopic debridement surgery of the knee to treat conditions such as meniscal injuries, chondral defects, and low-grade osteoarthritis.
Arthroscopic Debridement Surgery
Arthroscopic debridement surgery of the knee is performed to treat conditions such as meniscal injuries, chondral defects, and low-grade osteoarthritis.
Saline
Patients in the control arm of the study will receive arthroscopic debridement surgery along with a saline injection. This will be compared to the experimental arm, in which patients will receive arthroscopic debridement surgery along with a bone marrow aspirate injection.
RECRUITING
Hospital for Special Surgery, New York
Hospital for Special Surgery, New York
OTHER